Teladoc Health Shares Jump 4.4% After Deutsche Bank $11 Price Target Upgrade
Deutsche Bank upgraded Teladoc Health to Buy from Hold and set an $11 price target citing its low valuation and strategic reshaping of the BetterHelp unit. Shares jumped 4.4% following the upgrade, reflecting investor enthusiasm despite the stock’s 20.9% year-to-date decline and volatile trading history.
1. Deutsche Bank Upgrade
Deutsche Bank upgraded Teladoc Health’s shares to Buy from Hold and set an $11 price target, highlighting the telehealth provider’s low valuation and plans to reshape its BetterHelp unit to drive future growth.
2. Stock Reaction and Volatility
Teladoc shares jumped 4.4% in the afternoon session as investors responded positively to the upgrade, adding to a history of extreme volatility marked by 36 daily moves greater than 5% over the past year.
3. Q4 Results and Guidance
In the fourth quarter, Teladoc posted revenue of $642.3 million and narrowed its loss per share to $0.14 from $0.28 a year earlier, though guidance for the first quarter and full year came in below analyst forecasts.
4. Price Trends and Investor Returns
Year-to-date, the stock is down 20.9% and trading 41.1% below its 52-week high of $9.46, while a $1,000 investment five years ago would now be worth just $30.22, underscoring ongoing challenges in restoring shareholder value.